Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing antivenom therapy in children with carpet viper envenomation in northeastern Nigeria
PACTR202106915491232Phase 4Not yet recruiting
- Sponsor
- Bayero University Kano
- Start
- Jul 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in snakebite and carpet viper envenomation (2 arms), sponsored by Bayero University Kano. Primary endpoints: Restoration of blood clotting and Early adverse reactions. Planned start Jul 2021; status: not yet recruiting.
02
Conditions
snakebitecarpet viper envenomation
Beyond the preview
Go deeper on PACTR202106915491232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202106915491232.